Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial

Bibliographic Details
Main Authors: Busse, William W, O'Byrne, Paul M, Bleecker, Eugene R, Lötvall, Jan, Woodcock, Ashley, Andersen, Leslie, Hicks, Wesley, Crawford, Jodie, Jacques, Loretta, Apoux, Ludovic, Bateman, Eric D
Format: Online
Language:English
Published: BMJ Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664377/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664377/

Similar Items